Product Launch

  • Toyota bZ3 with BYD battery and motor starts accepting pre-orders in China with prices starting at $24,500

    The Toyota bZ3 is priced lower than the BYD Han EV in China, but higher than the BYD Destroyer 05.

  • Changan's EV brand Shenlan unveils its Model Y rival, S7

    Shenlan's first model is a rival to Tesla's Model 3 and has delivered a total of 37,328 units since deliveries began in late August.

  • Xpeng officially unveils P7i, facelift of P7, in China

    The P7 is a crucial model for Xpeng, contributing 49 percent of the company's sales in 2022.

  • Xpeng offering discounts to clear P7 inventory, facelift to launch next week, report says

    The new Xpeng P7 will be named P7i and will go on sale next week, when pricing information will be announced, according to local media.

  • Leapmotor delivers 3,198 vehicles in Feb, officially launches EREV model

    Leapmotor officially launched the C11 EREV and facelifts for its BEVs, allowing for significantly lower starting prices.

  • Geely officially launches Galaxy lineup, to roll out 7 models by 2025

    Geely Galaxy will launch four hybrid models and three all-electric models in the next two years to target the mass market.

  • Mercedes-Benz launches EQS SUV in China with starting price of over $132,000

    The EQS SUV is the latest offering from Mercedes-Benz in China, where it has previously released several all-electric models that have had lukewarm sales.

  • BMW launches 2 higher-priced variants of i3 EV in China

    The BMW i3 ranked 14th among the best-selling new energy sedans in China in January with 3,624 units sold, according to a list by the CPCA.

  • Regulatory filing: Human Horizons working on 3rd model HiPhi Y

    The HiPhi Y will be priced in the RMB 400,000-500,000 range and will be the least expensive of Human Horizons' models, previous reports have implied.

  • Regulatory filing: Zeekr X to be offered in 4- and 5-seat versions

    For a model of Zeekr X's size, a four-seat version is a rarity in China.